UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases... Show more
The 50-day moving average for UCBJF moved above the 200-day moving average on July 14, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Momentum Indicator moved above the 0 level on July 22, 2025. You may want to consider a long position or call options on UCBJF as a result. In of 53 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for UCBJF just turned positive on August 05, 2025. Looking at past instances where UCBJF's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where UCBJF advanced for three days, in of 15 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 184 cases where UCBJF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for UCBJF moved out of overbought territory on August 01, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 similar instances where the indicator moved out of overbought territory. In of the 20 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
UCBJF broke above its upper Bollinger Band on July 29, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.757) is normal, around the industry mean (18.662). P/E Ratio (27.907) is within average values for comparable stocks, (54.033). Projected Growth (PEG Ratio) (2.336) is also within normal values, averaging (2.909). Dividend Yield (0.007) settles around the average of (0.049) among similar stocks. P/S Ratio (5.429) is also within normal values, averaging (286.048).
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. UCBJF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
Industry Biotechnology
A.I.dvisor tells us that UCBJF and SHJBF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that UCBJF and SHJBF's prices will move in lockstep.
Ticker / NAME | Correlation To UCBJF | 1D Price Change % | ||
---|---|---|---|---|
UCBJF | 100% | +0.07% | ||
SHJBF - UCBJF | 30% Poorly correlated | N/A | ||
ALDX - UCBJF | 25% Poorly correlated | +1.64% | ||
GSGTF - UCBJF | 23% Poorly correlated | N/A | ||
SILO - UCBJF | 12% Poorly correlated | +10.15% | ||
TLPPF - UCBJF | 7% Poorly correlated | -2.65% | ||
More |